Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Auris Medical

(NASDAQ: EARS)
Add to Portfolio
-0.03 (-2.14%)
as of Dec 13, 2019

Last 1.37
Change -0.03 (-2.14%)
Open 1.37
Prev. Close 1.40
Today's Range
1.36
1.42
52wk Range
1.30
10.90
Volume 30,300
Avg Volume 106,685
Sector SIC-2834 Pharmaceutical Preparations

Perfomance Comparison

Name Today 3-Month 1-Year
EARS -2.14% -45.63% -84.78%
DJIA +0.01% +7.38% +14.38%
S&P 500 +0.01% +8.87% +19.55%

Key Statistics

Annual EPS -21.80
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 2,630
Weighted Alpha -83.40
Standard Deviation -0.57
Profit Margin N/A
Beta -0.55

Growth Rates

YTD -84.98%
1-Year -84.25%
3-Year -99.44%
5-Year -99.81%

Opinion

Sell Hold Buy

Recent Headlines

Auris Medical Announces Positive Interim Results from

GlobeNewswire via COMTEX - Fri Oct 11, 08:30AM EDT
Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced positive inte(full story)
EARS: 1.37 (-0.03)

Auris Medical Receives FDA and EMA Guidance for

GlobeNewswire via COMTEX - Fri Sep 13, 09:00AM EDT
Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced that it has o(full story)
EARS: 1.37 (-0.03)

Auris Medical Announces Appointment of New Chief

GlobeNewswire via COMTEX - Wed Sep 04, 07:13AM EDT
Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced the appointme(full story)
EARS: 1.37 (-0.03)

Auris Medical Announces Formation of Scientific

GlobeNewswire via COMTEX - Mon Aug 26, 09:00AM EDT
Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced the formation(full story)
EARS: 1.37 (-0.03)

Auris Medical Announces Randomization of First Patient

GlobeNewswire via COMTEX - Tue Jul 30, 08:30AM EDT
Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced that the firs(full story)
EARS: 1.37 (-0.03)